FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809841284> ?p ?o ?g. }

• W2809841284 endingPage "26" @default.
• W2809841284 startingPage "18" @default.
• W2809841284 abstract "Summary The therapy of deep venous thrombosis consists of several elements and depends on the localization, the age and the extent of the thrombus. In addition, the patient’s age and the life expectancy may influence the modality of treatment. The present overview discusses various types of initial therapy and long-term treatment of venous thromboembolism and also reviews future perspectives of pharmacological treatment. The initial treatment regimens comprise thrombolysis, thrombectomy, inferior vena cava filters and the anticoagulation with either unfractionated heparin or low molecular weight heparins. Thrombolysis is only effective in the initial phase of acute thromboembolic disorders, and the potential benefits must be balanced against the risk of hemorrhage. In the case of totally occlusive venous thrombosis, a successful outcome is more likely if the thrombolytic agent is infused into the thrombus via catheter directed thrombolysis. Thrombectomy should be considered in patients with acute iliofemoral venous thrombosis of less than seven days duration and a life expectancy of more than ten years. A filter device should be inserted in the inferior vena cava in patients with venous thrombosis above the knee when anticoagulation is contraindicated or when adequate anticoagulation fails to prevent recurrent embolism. The intravenous administration of unfractionated heparin has been the modality of choice for initial treatment of venous thromboembolism during several decades, however, this type of therapy requires an aPTT-adjusted dosing due to a broad interindividual variation of laboratory results. Numerous clinical trials have provided firm evidence that low molecular weight heparins given subcutaneously are significantly superior to intravenous, unfractionated heparin with regard to thrombus regression and reductions of severe hemorrhages, mortality and recurrent thromboembolism. Thus, these preparations may become the treatment of choice in the near future. Pulmonary embolism may be treated with low molecular weight heparins as well. Long-term treatment of venous thromboembolism is usually performed with oral anticoagulants. The recommended therapeutic range is an INR of 2.0 to 3.0, however the optimal duration of oral anticoagulant therapy for patients with acute proximal deep venous thrombosis is uncertain. Various thrômbin-inhibitors have been tested for initial treatment of thrombosis, however further investigations of their efficacy, safety and cost-effectiveness will have to provide firm evidence on their superiority when compared to unfractionated or low molecular weight heparins." @default.
• W2809841284 created "2018-07-10" @default.
• W2809841284 creator A5009167101 @default.
• W2809841284 date "1998-01-01" @default.
• W2809841284 modified "2023-10-16" @default.
• W2809841284 title "Management of venous thromboembolism" @default.
• W2809841284 cites W1592091620 @default.
• W2809841284 cites W1972706485 @default.
• W2809841284 cites W1979441861 @default.
• W2809841284 cites W1984286268 @default.
• W2809841284 cites W1989964518 @default.
• W2809841284 cites W2003915795 @default.
• W2809841284 cites W2007439488 @default.
• W2809841284 cites W2012850475 @default.
• W2809841284 cites W2013984355 @default.
• W2809841284 cites W2020475451 @default.
• W2809841284 cites W2033724005 @default.
• W2809841284 cites W2034586141 @default.
• W2809841284 cites W2049485678 @default.
• W2809841284 cites W2050424823 @default.
• W2809841284 cites W2051551497 @default.
• W2809841284 cites W2056946045 @default.
• W2809841284 cites W2073325230 @default.
• W2809841284 cites W2081406978 @default.
• W2809841284 cites W2087646765 @default.
• W2809841284 cites W2096668933 @default.
• W2809841284 cites W2140639517 @default.
• W2809841284 cites W2160179783 @default.
• W2809841284 cites W221137820 @default.
• W2809841284 cites W2214576528 @default.
• W2809841284 cites W2330454673 @default.
• W2809841284 cites W2333983635 @default.
• W2809841284 cites W2335699685 @default.
• W2809841284 cites W2338618131 @default.
• W2809841284 cites W2340468754 @default.
• W2809841284 cites W2340768556 @default.
• W2809841284 cites W2342200163 @default.
• W2809841284 cites W2411893053 @default.
• W2809841284 cites W2412718187 @default.
• W2809841284 cites W2418228359 @default.
• W2809841284 cites W2443272095 @default.
• W2809841284 cites W246989876 @default.
• W2809841284 cites W2512281683 @default.
• W2809841284 cites W55954674 @default.
• W2809841284 cites W57097576 @default.
• W2809841284 cites W84205322 @default.
• W2809841284 cites W2069630887 @default.
• W2809841284 cites W2498947101 @default.
• W2809841284 doi "https://doi.org/10.1055/s-0038-1655324" @default.
• W2809841284 hasPublicationYear "1998" @default.
• W2809841284 type Work @default.
• W2809841284 sameAs 2809841284 @default.
• W2809841284 citedByCount "0" @default.
• W2809841284 crossrefType "journal-article" @default.
• W2809841284 hasAuthorship W2809841284A5009167101 @default.
• W2809841284 hasConcept C141071460 @default.
• W2809841284 hasConcept C164705383 @default.
• W2809841284 hasConcept C177713679 @default.
• W2809841284 hasConcept C2776265017 @default.
• W2809841284 hasConcept C2776884760 @default.
• W2809841284 hasConcept C2777557582 @default.
• W2809841284 hasConcept C2779581417 @default.
• W2809841284 hasConcept C2780011451 @default.
• W2809841284 hasConcept C2780828045 @default.
• W2809841284 hasConcept C2780868729 @default.
• W2809841284 hasConcept C2781362458 @default.
• W2809841284 hasConcept C2910216633 @default.
• W2809841284 hasConcept C500558357 @default.
• W2809841284 hasConcept C71924100 @default.
• W2809841284 hasConceptScore W2809841284C141071460 @default.
• W2809841284 hasConceptScore W2809841284C164705383 @default.
• W2809841284 hasConceptScore W2809841284C177713679 @default.
• W2809841284 hasConceptScore W2809841284C2776265017 @default.
• W2809841284 hasConceptScore W2809841284C2776884760 @default.
• W2809841284 hasConceptScore W2809841284C2777557582 @default.
• W2809841284 hasConceptScore W2809841284C2779581417 @default.
• W2809841284 hasConceptScore W2809841284C2780011451 @default.
• W2809841284 hasConceptScore W2809841284C2780828045 @default.
• W2809841284 hasConceptScore W2809841284C2780868729 @default.
• W2809841284 hasConceptScore W2809841284C2781362458 @default.
• W2809841284 hasConceptScore W2809841284C2910216633 @default.
• W2809841284 hasConceptScore W2809841284C500558357 @default.
• W2809841284 hasConceptScore W2809841284C71924100 @default.
• W2809841284 hasIssue "01" @default.
• W2809841284 hasLocation W28098412841 @default.
• W2809841284 hasOpenAccess W2809841284 @default.
• W2809841284 hasPrimaryLocation W28098412841 @default.
• W2809841284 hasRelatedWork W120600296 @default.
• W2809841284 hasRelatedWork W2032613738 @default.
• W2809841284 hasRelatedWork W22889690 @default.
• W2809841284 hasRelatedWork W2375154040 @default.
• W2809841284 hasRelatedWork W2411475388 @default.
• W2809841284 hasRelatedWork W2475951558 @default.
• W2809841284 hasRelatedWork W3031791182 @default.
• W2809841284 hasRelatedWork W4205518343 @default.
• W2809841284 hasRelatedWork W4224239652 @default.
• W2809841284 hasRelatedWork W3029963180 @default.
• W2809841284 hasVolume "18" @default.

• next